Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
518
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Fysicon B.V. has been acquired by Canon Medical Systems
Healthcare

Fysicon B.V. has been acquired by Canon Medical Systems

Canon Medical Systems Corporation, a Japan-based developer of medical diagnostic imaging systems and medical solutions, has acquired Fysicon B.V., a developer of healthcare information systems in the Netherlands, for an undisclosed consideration.

Learn more
Ambry Genetics Corporation has been acquired by Konica Minolta, Inc.
Healthcare | TMT

Ambry Genetics Corporation has been acquired by Konica Minolta, Inc.

Ambry Genetics Corporation (Ambry), a clinical diagnostics testing services provider, has been acquired by Konica Minolta, Inc.

Learn more
Olea Medical has been acquired by Toshiba Medical Systems Corp.
Healthcare | TMT | Private Equity

Olea Medical has been acquired by Toshiba Medical Systems Corp.

The private shareholders of Olea Medical have sold the company to Toshiba Medical Systems Corporation, a wholly-owned subsidiary of Toshiba. Financial details have not been disclosed.

Learn more
“Oaklins’ team in Los Angeles understood our culture and history of innovation, and through the Konica Minolta partnership we will have the resources, technology and scale to advance biomedical research and enable the matching of more patients in more countries with specialized medicines that target the underlying cause of their illness.”

Aaron Elliott

CEO, Ambry Genetics Corporation

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=JP&includes=featured_images,tags&language=en&limit=1&tags=healthcare

New chapters, global ambitions: mid-market M&A in Q4

QUARTERLY M&A ACTIVITY: In Q4 2025, Oaklins' clients completed 93 transactions across sectors and regions, highlighting how business leaders are using M&A to drive growth, succession and strategic change.

Learn more

Talk to our local advisor

Toshiki Iino

Managing Director
Tokyo, Japan
Oaklins Maxus Corporate Advisory

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish